First Light Asset Management »

Kymera Therapeutics shares owned by First Light Asset Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $15M 383k 40.23
2024-09-30 $19M 406k 47.33

More positions owned by First Light Asset Management

Paragon 28 Common Stocks (FNA)
Centessa Pharmaceuticals Common Stocks (CNTA)
Axogen Common Stocks (AXGN)
Atricure Common Stocks (ATRC)
Twist Bioscience Corporation Common Stocks (TWST)
Vera Therapeutics Common Stocks (VERA)
Neogenomics Common Stocks (NEO)
Xenon Pharmaceuticals Common Stocks (XENE)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Irhythm Technologies Common Stocks (IRTC)
Health Catalyst Common Stocks (HCAT)
Performant Healthcare Common Stocks
Insmed Common Stocks (INSM)
Mimedx Group Common Stocks (MDXG)
Ultragenyx Pharmaceutical Common Stocks (RARE)

View all positions for First Light Asset Management

Top funds holding Kymera Therapeutics

T. Rowe Price Associates
Baker Bros. Advisors
Wellington Management Company
BVF
venBio Select Advisor
Atlas Venture Life Science Advisors
Vanguard Group
FMR
BlackRock
Siren
State Street Corporation
Driehaus Capital Management
Geode Capital Management
Redmile Group
Rock Springs Capital Management

View all funds holding Kymera Therapeutics